You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 5, May 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Controversies in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Statistics and Research Methods
 •Surgery
 •Vascular Surgery
 •Cerebrovascular Disease
 •Randomized Controlled Trial
 •Alert me on articles by topic

Should the Multicenter Carotid Endarterectomy Trials Be Repeated?

Seemant Chaturvedi, MD

Arch Neurol. 2003;60:774-775.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE 2 MAJOR clinical trials pertaining to carotid endarterectomy (CE) that were conducted in North America and published in the past decade were landmark clinical achievements. These studies, the North American Symptomatic Carotid Endarterectomy Trial (NASCET)1-2 and the Asymptomatic Carotid Atherosclerosis Study (ACAS),3 brought hard data to a surgical procedure that had been performed for decades but without clear efficacy. The NASCET study found that patients with recently symptomatic 70% to 99% angiographic stenosis had robust benefit from CE, with a 17% absolute difference at 2 years in terms of recurrent ipsilateral stroke compared with medical management.

The NASCET "high-moderate" group (50%-69% stenosis) and the ACAS cohort (60%-99% stenosis) had marginal benefits with surgery compared with medical treatment. The annual absolute difference was 1.3% in the NASCET high-moderate group and only 1.2% in the ACAS group. Many clinicians have found these differences not to be clinically meaningful.

. . . [Full Text of this Article]

From the Department of Neurology, Wayne State University, Detroit, Mich.


RELATED ARTICLES

Resolved: NASCET and ACAS Need Not Be Repeated: The Affirmative Position
Wesley S. Moore
Arch Neurol. 2003;60(5):775-778.
EXTRACT | FULL TEXT  

How Should We Design Studies for Stroke Prevention?
Steven T. DeKosky
Arch Neurol. 2003;60(5):778-779.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Carotid Artery Stenting Will Replace Carotid Endarterectomy
McCormick et al.
PERSPECT VASC SURG ENDOVASC THER 2007;19:223-227.
ABSTRACT  

ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
Bates et al.
Vasc Med 2007;12:35-83.
 

ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
American Society of Interventional & Therapeutic N et al.
J Am Coll Cardiol 2007;49:126-170.
FULL TEXT  

Carotid endarterectomy--An evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Chaturvedi et al.
Neurology 2005;65:794-801.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.